View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: 2G Energy AG steigert Auftragseingang im 1. Quartal um 26%

EQS-News: 2G Energy AG / Schlagwort(e): Auftragseingänge/Dividende 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% 18.04.2024 / 13:04 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% Auftragseingang erreicht 51,7 Mio. Euro (Vj.: 41,0 Mio. Euro) US-Markt überwindet Zurückhaltung und zeigt spürbares Wachstum (10,1 Mio. Euro; Vj.: 2,6 Mio. Euro) 2G verkauft in Deutschland die erste BHKW-Wärmepumpen-Kombination Vorstand und Aufsichtsrat schlagen eine Dividendenerhöhu...

 PRESS RELEASE

EQS-News: 2G Energy AG boosts order intake by 26% in 1st quarter

EQS-News: 2G Energy AG / Key word(s): Incoming Orders/Dividend 2G Energy AG boosts order intake by 26% in 1st quarter 18.04.2024 / 13:04 CET/CEST The issuer is solely responsible for the content of this announcement. 2G Energy AG boosts order intake by 26% in 1st quarter Orders reach EUR 51.7 million (previous year: EUR 41.0 million) US market overcomes caution and shows significant growth (EUR 10.1 million; previous year: EUR 2.6 million) 2G sells its first CHP/heat pump combination in Germany Management and Supervisory boards propose a dividend increase of 21% to EU...

Sun Hung Kai Properties Ltd: 1 director

A director at Sun Hung Kai Properties Ltd bought 601,500 shares at 69.841HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Tongcheng Travel Holdings Limited: 1 director

A director at Tongcheng Travel Holdings Limited sold 360,000 shares at 22.084HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

 PRESS RELEASE

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discus...

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live br...

 PRESS RELEASE

EQS-News: CureVac veröffentlicht am 24. April 2024 Finanzergebnisse de...

Emittent / Herausgeber: CureVac / Schlagwort(e): Sonstiges CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung 18.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung  TÜBINGEN, Germany/BOSTON, USA – 18. April 2024 – CureVac N.V. (Nasdaq: CVAC), ein biopharmazeutisches U...

 PRESS RELEASE

EQS-News: CureVac to Report Fourth Quarter and Full-Year 2023 Financia...

Issuer: CureVac / Key word(s): Miscellaneous CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 18.04.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024  TÜBINGEN, Germany/BOSTON, USA – April 18, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“m...

 PRESS RELEASE

Mawson Infrastructure Group Inc. Announces Monthly Operational Update ...

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024 Total Revenue Doubled with 100% Y/Y Growth from March of last year March Self-Mining Business Revenue up 182% Y/Y March Co-Location Business Revenue up 54% Y/Y March Total Revenue of about $5.44 million MIDLAND, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for March 2024. Rahul Mewawalla, CEO and President, commented, “We are very plea...

 PRESS RELEASE

SpringWorks Therapeutics to Report First Quarter 2024 Financial Result...

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates. To join the live webcast and view the corresponding slides, please click . To access the live call by phone, please p...

 PRESS RELEASE

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dress...

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention   Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon oc...

 PRESS RELEASE

Success for Terranet - tests conducted at AstaZero's test track valida...

Success for Terranet - tests conducted at AstaZero's test track validate BlincVision's potential Terranet AB (publ) has conducted tests in AstaZero's test environment and obtained positive outcomes for the company. The results demonstrate significant potential for the company's Advanced Driver Assistance System, BlincVision. The tests have been conducted at a Euro NCAP-approved test facility, meaning that these results directly contribute to Euro NCAP's ADAS rating methods for 2026. In the fall of 2023, Terranet was granted funding from the innovation agency Vinnova. The funding entailed c...

 PRESS RELEASE

Framgång för Terranet - tester utförda på AstaZeros testbana validerar...

Framgång för Terranet - tester utförda på AstaZeros testbana validerar BlincVisions potential Terranet AB (publ) har genomfört tester i AstaZeros testmiljö och erhållit för bolaget positiva utfall. Resultaten visar på stor potential för bolagets förarstödssystem BlincVision. Testerna har genomförts på en av Euro NCAP godkänd testanläggning, vilket innebär att dessa resultat direkt bidrar till Euro NCAP’s* ADAS betygsmetoder för 2026. Under hösten 2023 beviljades Terranet bidrag från innovationsmyndigheten Vinnova. Bidraget innebar att tillsammans med AstaZero utveckla nya provmetoder för a...

 PRESS RELEASE

BlackRock® Canada Announces April Cash Distributions for the iShares® ...

BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs Listing:TSX (Toronto Stock Exchange)  Symbol:CBH, CBO, CDZ, CEW, CLF, CLG, CMR, CPD, CUD, CVD, CYH, FIE, XAGG, XAGG.U, XAGH, XBB, XCB, XCBG, XCBU, XCBU.U, XDG, XDG.U, XDGH, XDIV, XDU, XDU.U, XDUH, XDV, XEB, XEI, XFLB, XFN, XFR, XGB, XHB, XHD, XHU, XHY, XIG, XIGS, XLB, XPF, XQB, XRE, XSAB, XSB, XSC, XSE, XSH, XSHG, XSHU, XSHU.U, XSI, XSTB, XSTH, XSTP, XSTP.U, XTLH, XTLT, XTLT.U, XTR, XUT  Listing:Cboe Canada (NEO Exchange Inc.)  Symbol:XGGB   TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- BlackRock Asset Managemen...

 PRESS RELEASE

Bio-Path Holdings Announces Successful Completion of Higher Dose Secon...

Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients BP1002 Offers Unique Opportunity for Venetoclax-Resistant AML Patients Utilizing RNAi to Limit AML Cell’s Ability to Produce Cancer Enabling Bcl-2 Protein HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announ...

 PRESS RELEASE

Benitec Biopharma Announces Oversubscribed Private Placement Financing...

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5,749,152 shares of its common stock at a price per share of $4.80, and, in lieu of shares...

 PRESS RELEASE

ECARX Announces Strategic Partnership with FAW Group to Develop Intell...

ECARX Announces Strategic Partnership with FAW Group to Develop Intelligent Cockpits for Its Premium Hongqi Brand SHANGHAI, China, April 18, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced a strategic partnership with China FAW Group Co., Ltd. (“FAW Group”), China’s leading automaker, to develop next-generation intelligent cockpits for the premium Hongqi brand of vehicles. ECARX and FAW will combine their considerable research and development capabilities and technological strengths to build an ...

 PRESS RELEASE

LanzaTech Announces Date for First Quarter 2024 Earnings Release and C...

LanzaTech Announces Date for First Quarter 2024 Earnings Release and Conference Call CHICAGO, April 18, 2024 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (Nasdaq: LNZA) (“LanzaTech” or the “Company”), the carbon recycling company transforming waste carbon into sustainable raw materials, today announced that it will issue its first quarter 2024 financial results before the market opens on Thursday, May 9, 2024. A conference call will be held that same day at 8:30 A.M. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. The confe...

 PRESS RELEASE

First Advantage to Release First Quarter 2024 Financial Results and Ho...

First Advantage to Release First Quarter 2024 Financial Results and Hold Investor Conference Call on May 9, 2024 ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, and verification solutions, will issue its first quarter 2024 financial results on Thursday, May 9, 2024 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. Conference Call Details To participate in the conference call, please dial 800-343-4136 (domestic) or 203-518-9843 (int...

 PRESS RELEASE

Mayfair Gold Announces the Appointment of Vice President Technical Ser...

Mayfair Gold Announces the Appointment of Vice President Technical Services MATHESON, Ontario, April 18, 2024 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) is pleased to announce the appointment of Richard Klue to the position of Vice President Technical Services of Mayfair Gold. Mr. Klue has over 40 years of experience in the mining, minerals, and metals industry, and has held numerous senior leadership positions overseeing global engineering studies, projects, and engineering programs. Most recently, Mr. Klue was Vice President Engineerin...

 PRESS RELEASE

Bacchus Capital Engaged as Strategic & Project Funding Adviser

Bacchus Capital Engaged as Strategic & Project Funding Adviser TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to announce that it has engaged Bacchus Capital Advisers Limited (Bacchus) as its strategic and project funding adviser in relation to the Kharmagtai Copper-Gold Project in the South Gobi region of Mongolia. Highlights Xanadu is executing a Pre-Feasibility Study (PFS) at its Kharmagtai copper-gold project, a 50-50 joint venture with Zijin Mining Group Co Ltd (Zijin). The PFS will be completed in Q3 CY2024...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch